PROBE Parallel 6-week Treatment Comparing Telmisartan/Hydrochlorothiazide (HCT) (40/12.5 or 80/12.5) With Losartan/HCT (50/12.5) Using Ambulatory Blood Pressure Monitoring (ABPM)

NCT00274638 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

805

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertension

Interventions

DRUG: Telmisartan & Hydrochlorothiazide
DRUG: Losartan & Hydrochlorothiazide
PROCEDURE: ABPM

Sponsor

Boehringer Ingelheim